Immunome Inc.

IMNM | NASDAQ

Price Alert Chart Builder DCF Calculator

$25.65

+$0.58 (+2.31%)

Sep 22, 2026, 2:21 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-212.39M	-292.96M	-106.81M	-36.9M	-24.71M	-17.84M
Depreciation & Amortization	2.96M	2.1M	728K	631K	755K	755K
Stock-Based Compensation	25.69M	15.75M	6.22M	5.33M	3.45M	621K
Other Working Capital	-6.06M	5.35M	12.61M	2.92M	998K	-1.71M
Other Non-Cash Items	8.06M	149.45M	80.29M	7.27M	4K	-2K
Deferred Income Tax	n/a	n/a	n/a	-7.27M	-500K	5.54M
Change in Working Capital	-15.23M	14.87M	12M	2.24M	2.78M	-1.21M
Operating Cash Flow	-190.92M	-110.79M	-7.57M	-28.69M	-18.23M	-12.13M
Capital Expenditures	-9.69M	-53.51M	-831K	-248K	-79K	-586K
Cash Acquisitions	n/a	n/a	9.28M	n/a	n/a	n/a
Purchase of Investments	-123.27M	-186.56M	-38.93M	n/a	n/a	n/a
Sales Maturities Of Investments	200M	155M	n/a	n/a	n/a	n/a
Other Investing Acitivies	-6.25M	-46.34M	n/a	n/a	n/a	n/a
Investing Cash Flow	60.8M	-85.06M	-30.48M	-248K	-79K	-586K
Debt Repayment	n/a	n/a	n/a	n/a	-113K	49K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-9.47M	116.37M	n/a	656K	-6M
Financial Cash Flow	640.36M	240.53M	116.41M	32K	27.77M	49.94M
Net Cash Flow	510.24M	44.67M	78.36M	-28.91M	9.46M	37.22M
Free Cash Flow	-200.6M	-164.3M	-8.4M	-28.94M	-18.31M	-12.72M
Adj. Free Cash Flow	-226.29M	-180.05M	-14.62M	-34.27M	-21.75M	-13.34M
Maintenance CapEx	-9.69M	-53.51M	n/a	-248K	-79K	-586K
Growth CapEx	n/a	n/a	-831K	n/a	n/a	n/a
Owner Earnings	-200.6M	-164.3M	-7.57M	-28.94M	-18.31M	-12.72M